Andere talen Harbin Gloria Pharmaceuticals Co., Ltd

Aandelen

002437

CNE100000QG8

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,02 ^CNY	+0,50%		-0,98%	-19,52%

12/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE:002437) heeft de verwerving van een extra belang van 10% in Harbin Dandelion Pharmaceuticals Co., Ltd. van Harbin Hanjun Investment Co., Ltd. afgerond.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	12/04
HARBIN GLORIA PHARMACEUTICALS Co., LTD completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd.	28-10-23
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
HARBIN GLORIA PHARMACEUTICALS Co., LTD agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million.	17-10-23
HARBIN GLORIA PHARMACEUTICALS Co., LTD(XSEC:002437) added to S&P Global BMI Index	18-09-23
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	28-07-23
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan	29-06-23
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan	29-06-23
Qingdao Pusheng Puli Enterprise Management Center (Limited Partnership) agreed to acquire 42.1204% stake in Guangzhou Gloria Biosciences Co., Ltd. from HARBIN GLORIA PHARMACEUTICALS Co., LTD for CNY240 million.	29-06-23
HARBIN GLORIA PHARMACEUTICALS Co., LTD announced that it expects to receive CNY 300 million in funding	15-05-23
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23
Consortium of buyers completed the acquisition of a 32.13% stake in Harbin Gloria Pharmaceuticals Co., Ltd from Harbin Gloria Group Co., Ltd.	07-04-23
Harbin Gloria Pharma Swings to Loss in 2022 on Asset Impairment	11-01-23
Harbin Gloria Pharmaceuticals Co., Ltd Announces Executive Appointments	21-12-22
Harbin Gloria Pharmaceuticals Co., Ltd Approves Executive Appointments	14-11-22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26-10-22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28-08-22
Guangzhou Gloria Biosciences Co., Ltd. announced that it expects to receive CNY 200 million in funding from Harbin Gloria Pharmaceuticals Co., Ltd	13-05-22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	25-04-22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	25-04-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Harbin Gloria Pharmaceuticals Co., Ltd

Aandelen

002437

CNE100000QG8

Andere talen

Filters